nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—peripheral nervous system neoplasm	0.407	1	CbGaD
Candesartan—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0634	0.162	CbGbCtD
Candesartan—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0462	0.118	CbGbCtD
Candesartan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0461	0.118	CbGbCtD
Candesartan—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0461	0.118	CbGbCtD
Candesartan—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0442	0.113	CbGbCtD
Candesartan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.032	0.0816	CbGbCtD
Candesartan—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0267	0.068	CbGbCtD
Candesartan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0197	0.0502	CbGbCtD
Candesartan—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0189	0.0483	CbGbCtD
Candesartan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0184	0.0469	CbGbCtD
Candesartan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.018	0.046	CbGbCtD
Candesartan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0123	0.0314	CbGbCtD
Candesartan—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.00133	CcSEcCtD
Candesartan—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00132	CcSEcCtD
Candesartan—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000262	0.00131	CcSEcCtD
Candesartan—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00026	0.0013	CcSEcCtD
Candesartan—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.0013	CcSEcCtD
Candesartan—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000259	0.00129	CcSEcCtD
Candesartan—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000259	0.00129	CcSEcCtD
Candesartan—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.00128	CcSEcCtD
Candesartan—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000256	0.00128	CcSEcCtD
Candesartan—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000256	0.00128	CcSEcCtD
Candesartan—Back pain—Etoposide—peripheral nervous system neoplasm	0.000254	0.00127	CcSEcCtD
Candesartan—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000253	0.00126	CcSEcCtD
Candesartan—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00125	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00125	CcSEcCtD
Candesartan—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00025	0.00125	CcSEcCtD
Candesartan—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00125	CcSEcCtD
Candesartan—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000248	0.00124	CcSEcCtD
Candesartan—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000248	0.00124	CcSEcCtD
Candesartan—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000248	0.00124	CcSEcCtD
Candesartan—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.00123	CcSEcCtD
Candesartan—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00123	CcSEcCtD
Candesartan—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00122	CcSEcCtD
Candesartan—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000245	0.00122	CcSEcCtD
Candesartan—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00122	CcSEcCtD
Candesartan—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00122	CcSEcCtD
Candesartan—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00122	CcSEcCtD
Candesartan—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000243	0.00121	CcSEcCtD
Candesartan—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.00121	CcSEcCtD
Candesartan—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00121	CcSEcCtD
Candesartan—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000242	0.00121	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000241	0.0012	CcSEcCtD
Candesartan—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00024	0.0012	CcSEcCtD
Candesartan—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00024	0.0012	CcSEcCtD
Candesartan—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00119	CcSEcCtD
Candesartan—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000238	0.00119	CcSEcCtD
Candesartan—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00118	CcSEcCtD
Candesartan—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00118	CcSEcCtD
Candesartan—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000236	0.00118	CcSEcCtD
Candesartan—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000235	0.00118	CcSEcCtD
Candesartan—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.00117	CcSEcCtD
Candesartan—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.00117	CcSEcCtD
Candesartan—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000233	0.00116	CcSEcCtD
Candesartan—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00116	CcSEcCtD
Candesartan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000231	0.00115	CcSEcCtD
Candesartan—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000231	0.00115	CcSEcCtD
Candesartan—Rash—Topotecan—peripheral nervous system neoplasm	0.000231	0.00115	CcSEcCtD
Candesartan—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00023	0.00115	CcSEcCtD
Candesartan—Cough—Etoposide—peripheral nervous system neoplasm	0.000229	0.00115	CcSEcCtD
Candesartan—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Headache—Topotecan—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Rash—Tretinoin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000229	0.00114	CcSEcCtD
Candesartan—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000228	0.00114	CcSEcCtD
Candesartan—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000228	0.00114	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00114	CcSEcCtD
Candesartan—Headache—Tretinoin—peripheral nervous system neoplasm	0.000227	0.00113	CcSEcCtD
Candesartan—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.00113	CcSEcCtD
Candesartan—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000227	0.00113	CcSEcCtD
Candesartan—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000226	0.00113	CcSEcCtD
Candesartan—Rash—Melphalan—peripheral nervous system neoplasm	0.000226	0.00113	CcSEcCtD
Candesartan—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000226	0.00113	CcSEcCtD
Candesartan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00112	CcSEcCtD
Candesartan—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000224	0.00112	CcSEcCtD
Candesartan—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00109	CcSEcCtD
Candesartan—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00109	CcSEcCtD
Candesartan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00108	CcSEcCtD
Candesartan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00108	CcSEcCtD
Candesartan—Nausea—Topotecan—peripheral nervous system neoplasm	0.000217	0.00108	CcSEcCtD
Candesartan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000217	0.00108	CcSEcCtD
Candesartan—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000216	0.00108	CcSEcCtD
Candesartan—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000216	0.00108	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00107	CcSEcCtD
Candesartan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00106	CcSEcCtD
Candesartan—Nausea—Melphalan—peripheral nervous system neoplasm	0.000213	0.00106	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00106	CcSEcCtD
Candesartan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00105	CcSEcCtD
Candesartan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00021	0.00105	CcSEcCtD
Candesartan—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000209	0.00105	CcSEcCtD
Candesartan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000209	0.00105	CcSEcCtD
Candesartan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000209	0.00105	CcSEcCtD
Candesartan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00104	CcSEcCtD
Candesartan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000207	0.00104	CcSEcCtD
Candesartan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00103	CcSEcCtD
Candesartan—Telmisartan—ABCB1—peripheral nervous system neoplasm	0.000205	0.658	CrCbGaD
Candesartan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00102	CcSEcCtD
Candesartan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00101	CcSEcCtD
Candesartan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000202	0.00101	CcSEcCtD
Candesartan—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000201	0.001	CcSEcCtD
Candesartan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000988	CcSEcCtD
Candesartan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000985	CcSEcCtD
Candesartan—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000981	CcSEcCtD
Candesartan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000971	CcSEcCtD
Candesartan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000193	0.000962	CcSEcCtD
Candesartan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000191	0.000955	CcSEcCtD
Candesartan—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000953	CcSEcCtD
Candesartan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000191	0.000952	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000952	CcSEcCtD
Candesartan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00019	0.000949	CcSEcCtD
Candesartan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.000941	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00094	CcSEcCtD
Candesartan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000939	CcSEcCtD
Candesartan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000933	CcSEcCtD
Candesartan—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000926	CcSEcCtD
Candesartan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000185	0.000925	CcSEcCtD
Candesartan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000924	CcSEcCtD
Candesartan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000185	0.000924	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000914	CcSEcCtD
Candesartan—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000908	CcSEcCtD
Candesartan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000908	CcSEcCtD
Candesartan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000181	0.000905	CcSEcCtD
Candesartan—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000898	CcSEcCtD
Candesartan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000888	CcSEcCtD
Candesartan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000883	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000881	CcSEcCtD
Candesartan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.000879	CcSEcCtD
Candesartan—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000879	CcSEcCtD
Candesartan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000176	0.000876	CcSEcCtD
Candesartan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000175	0.000875	CcSEcCtD
Candesartan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000873	CcSEcCtD
Candesartan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000865	CcSEcCtD
Candesartan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000865	CcSEcCtD
Candesartan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00086	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000856	CcSEcCtD
Candesartan—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000171	0.000851	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00085	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000847	CcSEcCtD
Candesartan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00017	0.000847	CcSEcCtD
Candesartan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.000847	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000845	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000845	CcSEcCtD
Candesartan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000168	0.000841	CcSEcCtD
Candesartan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000839	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000839	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000835	CcSEcCtD
Candesartan—Rash—Vincristine—peripheral nervous system neoplasm	0.000167	0.000834	CcSEcCtD
Candesartan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000167	0.000833	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000833	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000831	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000829	CcSEcCtD
Candesartan—Headache—Vincristine—peripheral nervous system neoplasm	0.000166	0.000829	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000822	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000817	CcSEcCtD
Candesartan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000815	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000813	CcSEcCtD
Candesartan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00016	0.0008	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000786	CcSEcCtD
Candesartan—Nausea—Vincristine—peripheral nervous system neoplasm	0.000157	0.000786	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000784	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000782	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000782	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000776	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000772	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00077	CcSEcCtD
Candesartan—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000154	0.000769	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000767	CcSEcCtD
Candesartan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000152	0.000758	CcSEcCtD
Candesartan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000744	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000741	CcSEcCtD
Candesartan—Rash—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000737	CcSEcCtD
Candesartan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000737	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000736	CcSEcCtD
Candesartan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000147	0.000733	CcSEcCtD
Candesartan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000712	CcSEcCtD
Candesartan—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000142	0.000708	CcSEcCtD
Candesartan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000695	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000685	CcSEcCtD
Candesartan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000136	0.000681	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000681	CcSEcCtD
Candesartan—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00068	CcSEcCtD
Candesartan—Rash—Etoposide—peripheral nervous system neoplasm	0.000135	0.000676	CcSEcCtD
Candesartan—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000135	0.000675	CcSEcCtD
Candesartan—Headache—Etoposide—peripheral nervous system neoplasm	0.000134	0.000671	CcSEcCtD
Candesartan—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000661	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000659	CcSEcCtD
Candesartan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000659	CcSEcCtD
Candesartan—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00065	CcSEcCtD
Candesartan—Cough—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000642	CcSEcCtD
Candesartan—Nausea—Etoposide—peripheral nervous system neoplasm	0.000127	0.000636	CcSEcCtD
Candesartan—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000635	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000629	CcSEcCtD
Candesartan—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000626	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000626	CcSEcCtD
Candesartan—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000626	CcSEcCtD
Candesartan—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000624	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000612	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000609	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000602	CcSEcCtD
Candesartan—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000594	CcSEcCtD
Candesartan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000588	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000588	CcSEcCtD
Candesartan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000586	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000581	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00058	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00058	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00058	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000578	CcSEcCtD
Candesartan—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000561	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000547	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000544	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000542	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000539	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000537	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000535	CcSEcCtD
Candesartan—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000534	CcSEcCtD
Candesartan—Losartan—ABCB1—peripheral nervous system neoplasm	0.000106	0.342	CrCbGaD
Candesartan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000529	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000519	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000518	CcSEcCtD
Candesartan—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000518	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000506	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000499	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000495	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000494	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000491	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000489	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.00048	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.000479	CcSEcCtD
Candesartan—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000477	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000475	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000475	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000454	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000441	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000439	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000439	CcSEcCtD
Candesartan—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000431	CcSEcCtD
Candesartan—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000425	CcSEcCtD
Candesartan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.23e-05	0.000411	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000399	CcSEcCtD
Candesartan—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000397	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000393	CcSEcCtD
Candesartan—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000382	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.00038	CcSEcCtD
Candesartan—Rash—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000379	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000378	CcSEcCtD
Candesartan—Headache—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000376	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000367	CcSEcCtD
Candesartan—Nausea—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000357	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000353	CcSEcCtD
Candesartan—Rash—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.00035	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.00035	CcSEcCtD
Candesartan—Headache—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000348	CcSEcCtD
Candesartan—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.00033	CcSEcCtD
